Aegerion Pharma Inc (AEGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -73,339 | -39,385 | -63,358 | -62,265 | -39,468 |
| Depreciation Amortization | 21,998 | 2,284 | 2,373 | 1,229 | 407 |
| Income taxes - deferred | 501 | N/A | N/A | N/A | N/A |
| Accounts receivable | 3,568 | -9,563 | -7,572 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,071 | 5,485 | -1,116 | 2,150 | -347 |
| Other Working Capital | 20,936 | -3,440 | -5,476 | 5,738 | 2,275 |
| Other Operating Activity | 41,246 | 42,568 | 36,662 | 10,591 | 6,624 |
| Operating Cash Flow | $15,981 | $-2,051 | $-38,487 | $-42,557 | $-30,509 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 64,118 | -22,084 | 787 | -45,903 |
| PPE Investments | -1,879 | -3,940 | -716 | -815 | -631 |
| Net Acquisitions | -325,000 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-326,879 | $60,178 | $-22,800 | $-28 | $-46,534 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 325,000 | N/A | 10,611 | 10,000 |
| Debt Issued | 24,962 | N/A | N/A | N/A | N/A |
| Debt Repayment | -29,539 | -90,223 | -3,022 | -10,000 | N/A |
| Common Stock Issued | 4,255 | 64,285 | 78,020 | 53,719 | 49,577 |
| Common Stock Repurchased | N/A | -35,000 | 10,038 | N/A | N/A |
| Other Financing Activity | -431 | -8,388 | 105 | -950 | -242 |
| Financing Cash Flow | $-753 | $255,674 | $85,141 | $53,380 | $59,335 |
| Exchange Rate Effect | 215 | 1,125 | -14 | 8 | -25 |
| Beginning Cash Position | 375,937 | 61,011 | 37,171 | 26,368 | 44,101 |
| End Cash Position | 64,501 | 375,937 | 61,011 | 37,171 | 26,368 |
| Net Cash Flow | $-311,436 | $314,926 | $23,840 | $10,803 | $-17,733 |
| Free Cash Flow | |||||
| Operating Cash Flow | 15,981 | -2,051 | -38,487 | -42,557 | -30,509 |
| Capital Expenditure | -1,879 | -3,940 | -716 | -815 | -631 |
| Free Cash Flow | 14,102 | -5,991 | -39,203 | -43,372 | -31,140 |